Brett Sutton – The Conversation

Shutterstock

November 28, 2022

Paxlovid is Australia’s first‑line COVID antiviral but Lagevrio also prevents severe disease in over‑70s

Benjamin Cowie, The Peter Doherty Institute for Infection and Immunity; Brett Sutton, Monash University; Christina Van Heer, The University of Melbourne, and Suman Majumdar, Burnet Institute

Analysis of Victoria’s winter COVID wave found Paxlovid and Lagevrio reduced the risk of hospitalisation and death. The results were better for Paxlovid, but not everyone can take it.

Shutterstock

February 27, 2020

It’s now a matter of when, not if, for Australia. This is how we’re preparing for a jump in coronavirus cases

Katherine Gibney, The Peter Doherty Institute for Infection and Immunity; Brett Sutton, Monash University, and Jodie McVernon, The University of Melbourne

There are three phases to Australia’s response plan. The ‘Initial Action’ stage, the ‘Targeted Action’ stage, and finally, the ‘Standdown’ stage. Right now, we’re in the first.

Contact Brett for